Wim Sluiter Selected Research

Wim Sluiter Research Topics

Disease

3	Heart Failure 01/2010 - 06/2005
3	Neoplasms (Cancer) 08/2007 - 01/2007
2	Infarction (Infarctions) 07/2011 - 01/2008
2	Hyperplasia 01/2003 - 09/2002
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Glycogen Storage Disease (Glycogenosis) 07/2012
1	Glycogen Storage Disease Type II (Pompe's Disease) 07/2012
1	Hypoxia (Hypoxemia) 05/2012
1	Carcinoid Tumor (Carcinoid) 10/2011
1	Reperfusion Injury 07/2011
1	Ischemia 06/2011
1	Pituitary Neoplasms (Pituitary Adenoma) 02/2011
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 10/2010
1	Mental Fatigue 10/2010
1	Ophthalmoplegia (External Ophthalmoplegia) 10/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2010
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2010
1	Cardiotoxicity 10/2010
1	Hypertension (High Blood Pressure) 10/2010
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 02/2010
1	Coronary Occlusion 01/2008
1	Ovarian Neoplasms (Ovarian Cancer) 08/2007
1	Muscle Spasticity (Spastic) 06/2007
1	Dystonia (Limb Dystonia) 06/2007
1	Carcinoma (Carcinomatosis) 06/2007
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2007
1	Wounds and Injuries (Trauma) 01/2007
1	Tissue Adhesions 11/2006
1	Cardiomegaly (Heart Hypertrophy) 08/2006
1	Ventricular Remodeling 08/2006
1	Fibrosis (Cirrhosis) 08/2006
1	Thrombosis (Thrombus) 11/2003
1	Lymphoma (Lymphomas) 10/2003
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2003
1	Hodgkin Disease (Hodgkin's Disease) 10/2003
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2002

Drug/Important Bio-Agent (IBA)

4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2008 - 01/2007
3	AntioxidantsIBA 01/2007 - 06/2005
2	Proteins (Proteins, Gene)FDA Link 02/2011 - 08/2007
2	Adenosine Triphosphate (ATP)IBA 10/2010 - 01/2008
2	Mitochondrial DNA (mtDNA)IBA 02/2010 - 06/2007
2	Superoxide DismutaseIBA 01/2007 - 08/2006
2	CatalaseIBA 01/2007 - 08/2006
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2003 - 01/2003
1	IodineIBA 01/2022
1	GlycogenIBA 07/2012
1	CreatinineIBA 07/2012
1	Biomarkers (Surrogate Marker)IBA 07/2012
1	Oxygen (Dioxygen)IBA 05/2012
1	Serotonin (5 Hydroxytryptamine)IBA 10/2011
1	CatecholaminesIBA 10/2011
1	Dihydroxyphenylalanine (Dopa)IBA 10/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2011
1	Phosphotransferases (Kinase)IBA 07/2011
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2011
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 07/2011
1	Growth Hormone (Somatotropin)IBA 02/2011
1	Tyrosine (L-Tyrosine)FDA Link 02/2011
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2010
1	Sunitinib (Sutent)FDA Link 10/2010
1	Endothelin-1 (Endothelin 1)IBA 10/2010
1	Tyrosine Kinase InhibitorsIBA 10/2010
1	Transcription Factors (Transcription Factor)IBA 01/2010
1	Protein Kinase CIBA 01/2008
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2008
1	Succinic Acid (Succinate)IBA 01/2008
1	salicylhydroxamic acid (SHAM)IBA 01/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2008
1	N-Formylmethionine Leucyl-PhenylalanineIBA 06/2007
1	EnzymesIBA 01/2007
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2007
1	Mannitol (Osmitrol)FDA LinkGeneric 11/2006
1	Free RadicalsIBA 08/2006
1	N,N'- bis(salicylideneamino)ethane- manganese(II)IBA 08/2006
1	Oxidants (Oxidizing Agents)IBA 08/2006
1	Apoptosis Inducing FactorIBA 08/2006
1	AnticoagulantsIBA 11/2003
1	Cisplatin (Platino)FDA LinkGeneric 10/2003
1	Ifosfamide FDA LinkGeneric 10/2003
1	Methotrexate (Mexate)FDA LinkGeneric 10/2003
1	Etoposide (VP 16)FDA LinkGeneric 10/2003
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2003
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2003
1	Vincristine (Oncovin)FDA LinkGeneric 07/2002

Therapy/Procedure

2	Radiotherapy 01/2022 - 02/2011
2	Therapeutics 10/2003 - 09/2002
1	Diet Therapy (Therapy, Diet) 06/2011
1	Hepatectomy 06/2011
1	Immunotherapy 08/2007
1	Induction Chemotherapy 10/2003
1	Stem Cell Transplantation 10/2003
1	Photochemotherapy (Photodynamic Therapy) 01/2003